CLDX CELLDEX THERAPEUTICS INC Investor Conferences 8-K Filing 2023 - Annual Meeting of Stockholders Celldex Therapeutics held its 2023 Annual Meeting of Stockholders, where stockholders voted on various proposals including the election of directors, ratification of the appointment of PricewaterhouseCoopers as the company's independent registered public accounting firm, and amendments to the company's equity incentive plan.Get access to all SEC 8-K filings of the CELLDEX THERAPEUTICS INC